HT
GSK icon

HAP Trading’s GSK GSK Stock Holding History

HAP Trading’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,080
Closed -$1.16M – 1398
2022
Q4 		$1.16M Buy
33,080
+6,008
+22% +$200K 0.12% 172
2022
Q3 		$797K Buy
+27,072
New +$1.03M 0.05% 285
2022
Q1 		– Sell
-17,798
Closed -$967K – 2457
2021
Q4 		$981K Sell
17,798
-4,316
-20% -$225K 0.03% 477
2021
Q3 		$1.06M Buy
+22,114
New +$1.11M 0.03% 457
2021
Q2 		– Sell
-35,854
Closed -$1.72M – 2496
2021
Q1 		$1.6M Buy
35,854
+12,756
+55% +$579K 0.09% 219
2020
Q4 		$1.06M Buy
+23,098
New +$1.06M 0.03% 409
2020
Q2 		– Sell
-16,715
Closed -$858K – 1785
2020
Q1 		$792K Buy
+16,715
New +$892K 0.05% 263
2017
Q3 		– Sell
-9,311
Closed -$472K – 955
2017
Q2 		$502K Sell
9,311
-2,926
-24% -$156K 0.03% 362
2017
Q1 		$645K Sell
12,237
-32,917
-73% -$1.67M 0.04% 302
2016
Q4 		$2.17M Buy
45,154
+26,384
+141% +$1.3M 0.11% 155
2016
Q3 		$1.01M Sell
18,770
-26,545
-59% -$1.46M 0.04% 261
2016
Q2 		$2.46M Buy
+45,315
New +$2.39M 0.14% 123
2016
Q1 		– Sell
-87,530
Closed -$4.36M – 894
2015
Q4 		$4.42M Buy
+87,530
New +$4.46M 0.21% 99
2015
Q1 		– Sell
-12,080
Closed -$693K – 1046
2014
Q4 		$645K Buy
+12,080
New +$676K 0.02% 405
2013
Q3 		– Sell
-32,240
Closed -$2.01M – 804
2013
Q2 		$2.01M Buy
+32,240
New +$2.05M 0.07% 236

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's GSK Position: Q1 2023 in Review

HAP Trading sold out of GSK (GSK) in Q1 2023, closing a stake of 33,080 shares — an estimated $1.16M sold.

HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $4.42M in Q4 2015. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • HAP Trading reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 33,080 GSK shares in Q1 2023, an estimated $1.16M.
  • HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters.
  • HAP Trading's GSK position peaked at $4.42M in Q4 2015.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.